A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. [electronic resource]
Producer: 20010125Description: 30-5 p. digitalISSN:- 1098-4275
- Bacterial Infections -- blood
- Blood Cell Count
- Cross Infection -- blood
- Double-Blind Method
- Granulocyte Colony-Stimulating Factor -- blood
- Granulocyte-Macrophage Colony-Stimulating Factor -- blood
- Hemoglobins -- analysis
- Humans
- Infant, Newborn
- Infant, Premature, Diseases -- drug therapy
- Interleukin-6 -- blood
- Platelet Count
- Recombinant Proteins
- Survival Rate
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.